Sino Biopharma is a Beijing-based corporate strategic investor and Chinese biopharmaceutical group focused on biotechnology, pharmaceuticals, life sciences and oncology. It invests in China and is relevant for biopharma and oncology companies seeking strategic capital, with later-stage venture activity including a co-led Series D investment.